The results of a nationwide, multicenter clinical trial provide solid evidence for the use of convalescent plasma as an early treatment for people with COVID-19. Researchers found that convalescent ...
In a recent study posted to the medRxiv* preprint server, researchers reviewed various randomized clinical trials and cohort studies to evaluate the decrease in mortality rates among coronavirus ...
The results of a nationwide, multicenter clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health provide solid evidence for the use of plasma from ...
A new analysis shows how convalescent plasma can be used to prevent hospitalizations and ultimately save lives, both for COVID-19 and for the next viral pandemic that inevitably arrives. Three years ...
Six months after it was controversially hailed by Trump administration officials as a “breakthrough” therapy to fight the worst effects of Covid-19, convalescent plasma appears to be on the ropes. The ...
Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma—a blood product collected from patients recovered from infections ...
During the Covid-19 pandemic, clinicians have seen many remarkable things. Among them is how a 19th-century therapy called convalescent plasma came to be used in more than 500,000 hospitalized ...
BioLife Plasma opened a new plasma center in Madison Jan. 30, their first to be open in the city and 14th open in the state, according to the Wisconsin State Journal. Plasma has been of particular ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A "definitive study" from Johns Hopkins University researchers and others shows that convalescent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results